BlueWind Medical is an innovative medical device company that aims to transform neuromodulation therapy for urge urinary incontinence (UUI).
The company developed Revi. Its advanced implant design allows for the device to be miniature in size without the need for replacement surgeries for battery change, lead migration, or lead fracture. Its innovative external wearable technology powers the implant for a patient-centric approach to therapy allowing for increases in energy and stimulation sessions based on the patients’ needs, giving patients the flexibility to ensure the best possible outcome.
BlueWind Medical has successfully completed several clinical studies with excellent results and is focused on bringing its implantable tibial neuromodulation system for the treatment of urge urinary incontinence to the market.
BlueWind Medical was founded by the Rainbow Medical Group.
Cumulative Funding Raised Over Time ($)
Employees Over Time
BlueWind Medical Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
May 14, 2026
www.businesswire.com
BlueWind Medical Secures $47.8 Million Financing to Accelerate Commercialization of Revi® System
null
Dec 21, 2023
www.prnewswire.com
BlueWind Medical Brings Revi Implantable Tibial Neuromodulation Device to Patients in Shreveport, Louisiana
#Customers, Expand
Aug 16, 2023
www.prnewswire.com
BlueWind Medical's Revi™ System Secures U.S. FDA De Novo Classification Grant for the Treatment of Urgency Incontinence
#Customers #Partners
May 1, 2023
www.prnewswire.com
Clinical Study Results of the BlueWind System for Patients with Overactive Bladder Featured at the 2023 AUA Annual Meeting
#Customers
Apr 24, 2023
www.prnewswire.com
BlueWind Medical to Present Positive Results from its Pivotal Trial in Patients with Overactive Bladder at the 2023 AUA Annual Meeting